- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Pleasanton Today
By the People, for the People
Calyxo Raises $40 Million for Kidney Stone Treatment Device
The medical device company's CVAC system has now treated over 40,000 patients.
Apr. 14, 2026 at 5:15pm
Got story updates? Submit your updates here. ›
Calyxo's innovative CVAC system, a non-invasive medical device for treating kidney stones, has now been used to help over 40,000 patients.Pleasanton TodayCalyxo, Inc., a California-based medical device company focused on kidney stone treatment, has announced the closing of a $40 million Series F financing round. The company's CVAC system, which uses a novel approach to treat kidney stones, has now surpassed 40,000 patients treated.
Why it matters
Kidney stones are a common and painful condition that affects millions of people each year. Calyxo's innovative CVAC system provides a new treatment option that could help improve outcomes and reduce the burden on patients and the healthcare system.
The details
The $40 million Series F financing will help Calyxo continue to develop and commercialize its CVAC system, which uses a proprietary approach to break up and remove kidney stones without invasive surgery. The company says the system has now been used to treat over 40,000 patients since its introduction.
- Calyxo announced the $40 million Series F financing on April 14, 2026.
The players
Calyxo, Inc.
A medical device company focused on developing innovative treatments for kidney stones.
What’s next
Calyxo plans to use the new funding to further expand the availability and adoption of its CVAC system for kidney stone treatment.
The takeaway
Calyxo's successful Series F funding round and the growing adoption of its CVAC system highlight the continued need for innovative medical technologies to address common health issues like kidney stones.
